Abstract The Global Initiative for Asthma (GINA) was established in 1993 by the World
Health Organization and the US National Heart Lung and Blood Institute to improve asthma …

Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and
annually updated a global strategy for asthma management and prevention that has formed …

About 334 million people worldwide suffer from asthma, and this figure may be an
underestimation. It is the most common chronic disease in children. Asthma is among the top …

Background Respiratory syncytial virus (RSV) infection is associated with subsequent
recurrent wheeze. Observational studies cannot determine whether RSV infection is the …

Asthma is the most common chronic lower respiratory disease in childhood throughout the
world. Several guidelines and/or consensus documents are available to support medical …

Asthma is a global health problem affecting around 300 million individuals of all ages, ethnic
groups and countries. It is estimated that around 250,000 people die prematurely each year …

In global terms, respiratory viral infection is a major cause of morbidity and mortality. Infancy,
in particular, is a time of increased disease susceptibility and severity. Early-life viral …

Asthma is the most prevalent chronic respiratory disease both in children and adults and
resembles a complex syndrome rather than a single disease. Different methods have been …

Childhood asthma represents a heterogeneous challenging disease, in particular in its
severe forms. The identification of different asthma phenotypes has stimulated research in …

Background Eczema, rhinitis, and asthma often coexist (comorbidity) in children, but the
proportion of comorbidity not attributable to either chance or the role of IgE sensitisation is …